Literature DB >> 11732530

Sex and oestrous cycle differences in visceromotor responses and vasopressin release in response to colonic distension in male and female rats anaesthetized with halothane.

A Holdcroft1, S Sapsed-Byrne, D Ma, D Hammal, M L Forsling.   

Abstract

Visceromotor responses and vasopressin release before and after colonic visceral distension were compared between male (n=5 (n=4 for vasopressin)) and female rats and between females during the oestrous cycle (proestrus n=6, oestrus n=5, metestrus n=5, diestrus n=6) at a controlled depth of anaesthesia. Pre-stimulation vasopressin and blood pressures demonstrated oestrous cycle variability. The mean (SEM) colonic balloon pressure triggering visceromotor responses was significantly higher in males (64 (4) mm Hg) than females (41 (1) mm Hg), P=0.002 and within females, proestrus rats had the lowest thresholds, (29 (1) mm Hg, P<0.01). Post-stimulation, vasopressin concentrations increased significantly in all groups (males 1.34 (0.39) to 2.24 (0.74) pmol litre(-1); females 1.54 (0.24) to 2.88 (0.58) pmol litre(-1); P=0.002). Within groups statistically significant differences were measured in proestrus 2.06 (0.56) to 3.42 (1.12) and oestrus 1.16 (0.38) to 2.76 (0.60) pmol litre(-1) (P<0.05). High vasopressin concentrations coupled with low-pressure stimulation during proestrus shows sex-hormone dependent integration of the neuroendocrine response to noxious visceral stimulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11732530     DOI: 10.1093/bja/85.6.907

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  14 in total

1.  Spinal cord processing of cardiac nociception: are there sex differences between male and proestrous female rats?

Authors:  Janine M Little; Chao Qin; Jay P Farber; Robert D Foreman
Journal:  Brain Res       Date:  2011-07-23       Impact factor: 3.252

2.  The expression of the clock protein PER2 in the limbic forebrain is modulated by the estrous cycle.

Authors:  Jennifer S Perrin; Lauren A Segall; Valerie L Harbour; Barbara Woodside; Shimon Amir
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-22       Impact factor: 11.205

3.  Sex differences in functional brain activation during noxious visceral stimulation in rats.

Authors:  Zhuo Wang; Yumei Guo; Sylvie Bradesi; Jennifer S Labus; Jean-Michel I Maarek; Kevin Lee; Wendy J Winchester; Emeran A Mayer; Daniel P Holschneider
Journal:  Pain       Date:  2009-06-26       Impact factor: 6.961

Review 4.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

5.  Estrogen modulation of peripheral pain signal transduction: involvement of P2X(3) receptors.

Authors:  Bei Ma; Li-Hua Yu; Juan Fan; Binhai Cong; Ping He; Xin Ni; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-01-06       Impact factor: 3.765

6.  Neonatal stress from limited bedding elicits visceral hyperalgesia in adult rats.

Authors:  Yumei Guo; Zhuo Wang; Emeran A Mayer; Daniel P Holschneider
Journal:  Neuroreport       Date:  2015-01-07       Impact factor: 1.837

Review 7.  Sex differences and hormonal modulation of deep tissue pain.

Authors:  Richard J Traub; Yaping Ji
Journal:  Front Neuroendocrinol       Date:  2013-07-17       Impact factor: 8.606

Review 8.  Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.

Authors:  Mathieu Meleine; Julien Matricon
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

9.  The visceromotor response to colorectal distention fluctuates with the estrous cycle in rats.

Authors:  Y Ji; B Tang; R J Traub
Journal:  Neuroscience       Date:  2008-05-07       Impact factor: 3.590

10.  Estrogen receptor β activation is antinociceptive in a model of visceral pain in the rat.

Authors:  Dong-Yuan Cao; Yaping Ji; Bin Tang; Richard J Traub
Journal:  J Pain       Date:  2012-06-13       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.